d y patil university school of medicine basic workshop …€¦ · lecture dr. y.s. nandanwar asso....

D Y Patil University School of Medicine BASIC WORKSHOP

RESEARCH METHODOLOGY (2019)

The workshop was organized jointly by Institutional Ethics Committee (IEC), D.Y.

Patil University School of Medicine, Dept. of Obstetrics & Gynaecology and

supported by Abbot pharmaceuticals.

The workshop was conducted on 22/7/2019 – 24/7/2019 in “PUSHPANJALI”

auditorium of Dr.D.Y.Patil University School of Medicine & Hospital, Navi-

Mumbai from09:00 AM to 4.00PM. It was conducted under the guidance &

active participation By organizing secretary Dr Deepak Langade Prof. & head

department of pharmacology & Dr.Meena Satia prof of OBGY.

A total of 173 participants were there which included faculties & Post graduate

students from 2019-2020 batch.

Dr Bharti Kulkarni Prof & Head of paediatric surgery & Dr Vijaya Badhwar , Prof.

of OBGY ,DYPSOM, Navi-Mumbai has inaugurated the programme with well

come address by Dr Meena Satia.

Various speakers who spoke on aspects of Research methodology were Dr Dr

Meena Satiya, Dr Deepak Langade, Dr Abhay Chowdhary, Dr Anant patil , Dr

Vaishali Thakare, Dr Vidita Morepatil , Dr Nirmala Rege, Dr Padmja Sawant, Dr

Pratap Jadhav.

The workshop was concluded by valedictory function & certificate distribution

by Dr. Surekha Patil, Dean , DYPSOM, Nerul

Contact: [email protected] / [email protected] 9930550009 1

Basic Workshop on

RESEARCH METHODOLOGY

22 – 24 July 2019

[09:00 AM – 04:00 PM]

Venue

Pushpanjali Auditorium, 1st floor, D.Y. Patil Hospital, Nerul, Navi Mumbai

Organized by

Department of Obstetrics & Gynecology and Institutional Ethics Committee (IEC), Department of Pharmacology

Organizing Secretary

Dr M. N. Satia, Dr. Deepak Langade Contact: [email protected] / [email protected]

98690 84018 / 99305 50009

mailto:[email protected]




D.Y. Patil University School of Medicine

BASIC WORKSHOP ON RESEARCH METHODOLOGY Organizing Secretary: Dr M.N.Satia, Dr. Deepak Langade


DAY 1, MONDAY 22 JULY 2019

Time Topic Method Faculty

8.30-9.00 Registration & Pretest -

9:00-9:45 L-1 Welcome & Introduction to Research Methodology Management of Shock and Blood Transfusion in Obstetrics

Lecture Dr. Meena Satia Prof. of Ob. Gyn.

09:45-10:15 L-2 Scope of Research Methodology

Lecture Dr. Abhay Chowdhary Prof. & Head, Microbiology

10:15-11.00 L-3 Research Question, Study Designs & Hypothesis

Lecture Dr. Deepak Langade Prof. & Head, Pharmacology

11.00 - 11.15 Tea

11.15-12.15 L-4 Research Protocol Lecture Dr. Anant Patil Pharmacology

12.15-12.45 • GA-1 (Group Activity) Participants will be divided into 4 groups.

• Each group will discuss and come out with at-least 2 research questions and related hypotheses

• Indicate why the topic was selected

• Type of study of study design

Group Activity

Dr Anant Patil Pharmacology Dr. Kavitha VD Dr. Vaishali Thakare

12.45 - 1.15 pm Lunch

1.15-2.00 L-5 Quantitative Research Methods Lecture M. N. Satia, Professor Ob. Gyn. Dr Kavitha VD Pharmacology

2.00-3.15 • GA-2: Divide into groups and discuss and present

• Indicate why the topic was selected, Indicate type of study

• Indicate dependent and independent variables in the study

Group Activity

3.15 - 3.30 pm Tea

3.30-4.30 L-6 Principles of GCP Guidelines Documents in Healthcare Research

Lecture Dr. Vidita Morepatil Abbott India Ltd.

4.30 - 4.45 Day One feedback






DAY 2, TUESDAY 23 JULY 2019


9.00-10.00 L-7 Qualitative Research Methods Lecture Dr. Padmaja Samant Professor Ob. Gyn.

10.00-11.00 L-8 Ethical Issues in Research

• GA-3: Groups will present ethical issues in their respective studies

Lecture & Group Activity

Dr. Padmaja Samant Professor Ob Gyn. Seth G.S. Medical College

11:00-11:30 L-9 RPA Lecture Dr. Vijaya Badhwar Professor Ob. Gyn.

11:30 - 11:45 Tea

11:45-12:30 L-10 Sampling Methods Lecture Dr. Mrudula Solanki Prof. Community Medicine Seth G.S. Medical College

12.30-01.00 L-11 Literature search

• GA-4: Participants will be divided into groups

• Each group will try to search references related to topics finalized and discussed


Dr. Anant Patil Asst. Prof. Pharmacology Dr Kavitha Vivek Asst. Prof. Pharmacology

01.00 - 1.30 Lunch

1.30-2.15 L-12 Introduction to Biostatistics, Descriptive Statistics

Lecture Dr. Pratap Jadhav Biostatistician Seth G.S. Medical College

2.15-3.00 L-13 Hypothesis testing & Inferential Statistics

• GA-5: The groups will discuss about the inferential statistics (statistical tests) to be applied for the study design discussed in earlier group exercises


Dr. Pratap Jadhav Biostatistician Seth G.S. Medical College

3.00 - 3.15 Tea

3.15-4.30 L-14 Sample size in research

Lecture Dr. Vidita Morepatil Abbott India Ltd.

4.30 - 4.45 Day Two Feedback






.

DAY 3, WEDNESDAY 24 JULY 2019


09.00-09.30 L-15 Hand hygiene and Management of sharps in labour room & OT

Lecture Dr. Y.S. Nandanwar Asso. Prof. Ob Gyn.

9.30-10.45 L-16 Questionnaire designing Lecture Dr. Nirmala Rege Prof. Emeritus in Pharmacology Seth G.S. Medical College

10.45 - 11.00 Tea

11.00-12.15 L-17 Submission of Synopsis Lecture Dr. Vaishali Thakare Asso. Prof. Pharmacology

12.15-1.00 L-18 Regulations in Research Lecture Dr. Deepak Langade Prof. & Head, Pharmacology

1.00 - 1.30 Lunch

1.30-2.00 L-19 Roles & Responsibilities of Researcher / Investigator

Lecture Dr. Varsha Vyas Prof. of Anesthesiology

2.00-3.00 L-20 Critical Evaluation of Journal Article

• GA-6: Journal articles (different study designs) will be presented and discussed by members


Dr. Vidita Morepatil Abbott India Ltd.

3.00 - 3.30 Post-test, Day 3 feedback & Workshop evaluation



Workshop on Research· Methodology

I El

1 0--< f(, . .n--a f?apo,4

2 ¥' s

7

1 l

l 2 ~r {), . ft n - ·' J ·Jv ,_ (3)~(lv\,A ..

13 r c[s\,tara.h \{l k-4r"· ~B

Dept.

"j R \

22-24 July 2019

Sig nature

1

Workshop on Research Methodology 22-24 July 2019

Na111~ 0Jitl11 tl I I •1 Dept. Signature

21 f),t . jvu;t,• }1~ 10.k

28 bA s~k_g.~ fv1

30

3 1

32

33

34

36 '1)y , /<o.1lo~

2

I Workshop on Research Methodology 22-24 July 2019

Na111~ ,i ftl I t Dept. Sig nature

40

I') y. CY I in KlJlrat \

4 1 ·

42

4 3

44

4 7 I_,,( . ~ J ~

50 i)-'1 . ~ush~1' ~ ~v-iob,'o l·

54

55

3

Workshop on Research M ethodology 22-24 July ?019

Na1111.: ot'31 , ile 11 Dept. Signature

68

69

70

72 J), . ~~· SonQuJQnc FMT

4

\

~ - 'N~v-.,,\~;~1.-,,y Na.r0w ~ t-. p-, v.J~~ ~ ,~rmt1tvl1;( Dy . k .._ v f R,,_ . V · j) o "J' .- I« J 'f'i-.. r,,A"-'-OI j f ~y,,;;::::---

Th\" . ~~ ~cJ "'a D 'F, €j, $7,,-J>l . MtL.Lt A-tu)~

I

•

I r- .... ~ ~~ j i"-'

~/ Name t..f•flii iilt:1l~ t ,,

I Dr. ·Sonalika Rajc:sh Ouµhar

)

Ur. Niti Hhat\\ ;d -

' I >r San_j: 111:j an_j a-' Ma lnkar '

., Ur. l ri\ ed i Su111cdha An iruddh

:-, Ur. J ig_\asa Rcgni

() I )r. -Lainabkhanam Airani

Dr Alla 111111.:11_i Sai Sr:n anthi

8 IJR.RIYA \1 /\NSURI

l) DIC l\1AI l'H.I KIS I IOR MEHTA

I() Dr.HI IA VISI IYA SUN OAR

11 DR, RINU-: I IARRIS

I:' DI< SI lll<S,'\ I I\AGlSI I KUMAR Ill 1/\!\ l 11),\S

1.1 l>r Ma li A111ey Ra_jt:ndra

,., I )r Soha111 Sha11kar Udayshankar ( ·1ia11c1:il'l'

l :'i Dr.Sharclul Sanja) Dt:slmiukh

I(> l)r._l'ra11,11 Dha, a l Modi

Workshop on Research Methodology 22-24 July 2019

Dep1. Signature

,.--,..

_ \i) ~ MO General Medicine V

~

MU Gelll:ral Medicine ~ MIJ (ielll:ral Medicine ~ MO General Medicine ~~ MD General Medicine ~❖ MD Genera l Mcdiaine ~ MO General Medicine A~ ~ · - -

MO Genera l Medicine ~ MD Genera l Medicine

MD General Medicine ~ Y.·· -~

MD Genera l Medicine ~ -V

. MO Genera l Medicine ~A',n_2b

~ ~

MD Genera l Medicine ~ MO General Medicine ~~

MD Genera l Medicine ~ I ,,_..

M IJ Pul111onary M~dicine ~ I ~ V

1

,, .J 1 ...... Workshop on Research Methodology 22-24 J uly 2019

F..cs~

~~

~ I / Name c,;f II 11! ~ 1:li:ilt Dept. Signatu re ,, )J_.v~~ 17 l)r.Ka111111ara Vinod Ad1ari MD Pulmonary Medicine

I

~-~ IS Dr 1':and itha V cn!.,.atram reddy MD Pulmonary Medicine

Ii a{,,. LoMD. .

i i j'-) Dr. Ni111111~ r-.1. R. Ml:T1' ul111011clf") Medicine ~ 20 I )r. l't'j;h\1 i11i -;hckhar Sharma

f'vllJ Dermatology . ~~ Ycnercolog~ & Leprosy / -

21 l)r. A:,\1 ath~ Radhakrishnan MIJ Skin / Dermatology (~k · 1 V

\, . .,., IJr. M. l3a11dha\ i MD Dermatology t,~ --

.., ' __ ) Dr. Rec~ a I I itcndrabhai Patel MD Dermatology

2-~ Dr. A111i1a Pandurang Nayak IJiploma in Dermatology.

~ -Venereolog) and Leprosy

. 2) I >r. Shi\ ani Rajcsh Shah MIJ l's)chi,llry ~

26 IJr. Patt'I Ohan.I\ l3ipinkutllar MD Psychiatr) ~ 27 IJr. Vaidchi Manohar Arwari MD Psychiatry ~;,.~

28 l)r. .Pa llavi Ashish Wadhawan MD Paediatrics "?41~\)l~ - -'.; l) l>r. Vidisha Oi m:sh Uaiya MD Paediatrics ,,))~ JO Ur. Sushil Vija) Ye\1ak MD Paediatrics fk--;i l>r l{~· \:1111h S;1i Madh,I\ U MD Paediatrics ~p_~

. ,.., DR.SRO/\ SANIY A \/VJ\ J,v t .)_ MD Paediatri.cs SUKI IJITKUMAR

l ~

2

-t --'6; Workshop on Research M~thodology 22-24 J I ~ p u/y 2019

(

~~- / ,\,lflll' ~II iaiw1 I ii Depr. I

OR . OESHPANOE VEDASHR Signature 1 ' ' J _l EE U/ IA.l\'ANJA y MD Paediatrics <l)~tV~=:- .

3~ Or. _N Santosh Kumar Diploma in Child J:lealth

' -" I Jr 1'.amlesh Janghel Oiploma in Child Hea lth

3-6 Dr Ra \'Uri Go\\ thami Diploma in Child Hea lth

37 Or. Vishat-.ha Mahe11dra Patel MD Radio Diagnosis / Radiology

38 Dr. Renul..a Sanja) lndurkar MD Radio Diagnos is / ~~~~ Radiology

3') Dr. Ja~pred Kaur Da lip S ingh MO Radio Diagnosis /

~ Radio logy

lu Ur. ,\dit:a Rah.e~h l\a l:rnade 1\11) Radio Diagnos is / ~ Radiolog)

l)R .SHRA VAN SH RI KANT MD Radio Diagnos is I ~ -1.1 PATIL Kadio log)

DR SI l~l I !\1II K/\FLE MD Rad io Diagnosis /

~ -I ~ Radio log).

11 l)r. Ritil..a Madan La l Khura11a MO Patho logy ~ ' /

·1 I Dr. /\ h.sh.i) harinder l..u111ar

MD Pathology ~ I\ ~•In, a I

' .v _ 1., Dr. l) j , : a ,'vla.:hc, ur MIJ Pathology -

' -16 IJI< . Sou111> a l'ande MO Pathology

~ ......

•17 Dr.Di,> a Oayanand Pa til MO Patho log.y

·18 Dr A~,mari Sujendra Arwit-.ar MD Patho logy ~ 3

1

Workshop on Research Methodology

Name~1 '' f Depr.

~cJ Or.Tririsri Vas Diploma in C/inca/ Par/Jo logy

5U Dr. /Jhokare Vis/Jak/Ja Sonyabapu Diploma in Clinca/ Par ho logy

.~ I I >r. l-luda !\ Ii Sayed MD Microbiology

52 Ur. rn,nn Ambegaokar MV P/Jam,aw/og}

53 Dr. Sane /{ohi1 Mahesh MS Orthopaedics

5 I IJr. Anura~deep Joydeep Syal MS Orthopaedics

55 Or.Al-.sha1 Mukul Pandey MS 0 11/Jopaedics

56 Dr.Shiva111 Mehra MS Orthopaedics

57 I>,:. l'ar iJ l'vlai lre)a Jagdi5h Maya MS U11hopaedics

5 Ii Dr. Kumar Abhint:cl Chand MS Orthopaed ics

59 IJIU<AJA GANES I J J<A YUOU .P MS Orthopaedics

DR KANDAGATLA SAC/ II N MS Orthopaeaics 60

Sl // )/\ RSH/\N

61 Dr YcJsh J,1) ,1111i lcJ I 1-.ad i\'il r Diploma in Orthopaed ics

<,~ I k .Shn.:.\i111~ I h:1 11a111 Gandhi Diploma i11 Orthopaedics

6 l I )r. Sha111,1111, V ijay_ Diploma in Onhopaedics

6-l Dr. P. Blii11 ana MO Anaesthes iology

/ Signature I

I

I

22-24 July 201 9

I

4


fai.1

/)r. //Jakur Lnanya Atul Kumar I /,;1kur

Dept.

66 Or. Nelia Sa, ,jay Kumar Singha/ MD Anaesthesiology

67 Ur. Gurn1i11der Singh Panesar · MD Anaesthesiology

68 Dr. Pralh) usha Yaggar i MD Anaesthesiology

69 Or.Pn,rha /' Oa11d,111ate MD Anaesrhcsio/og)

70

71

Or Pa11hk u111ar Ranchhodbhai I I irpara

Dr. Sireesha Devi Kandregula

MD Anaesthesiology

Diploma in Anaesthesia

72 Dr.Anurita Singh Diploma in Anaesthesia

73 Dr Kanika Kripa Shanker Rai MS ENT

7..J Or ShiHI Kumar IJivil) MSENT

75 Or. Akshada V ithal Dhuma/ MS ENT .

76 IJ, ·. Dipi11 K Dip/onrn in ENT

77 I),-. Agr,11\al Soumyaa Anand Ne enw MS OBGY

78 I Jr. Shahasane /\11ki1a Ni1i11 MS OBGY

7 1) DR . IJFLPIKA GlJI.ATI M DIMS Obstetrics & G) naei.:o/og)

Xu I )r .

'/ ,-

~~·

~ ~ ~

Jt~ ·1ri1edi Harita Manish Di p/0111a in Obstet rics &

~ G) naecoloo1 "-

22-24 July 2019

5

I )r. Sabha11 i Akashk1111111r /Jhara111sh ib/iai


Dept.

Diploma in Obstetrics & Gynaecology

n -24 July 2019

Dr. Khanna Ros/111i N••e,-,,1· R,, 1 . Diploma in Obstetrics & "" oS l/TII ·

· Gynaecology ~_..

83 Dr. DoctorSumerKum,·1r MSO I I I ~ p 11 1a mo/ogy

r-r~-~-__:__~::::.....:....· - ____, .~ I I )r. \ 1a11a~i Salish More MS Oph1ha/11ro/oµy V

· 85 Dr. ARORA MILLI PRADEEP MS Ophthalmology

MONICA

86 l )r Nelrn Ajir Ohakappn Diploma in Ophthalmology

87 Dr.Gautam Pravinbhai Jobanputra MD Emergency Medicine

88 Dr Mohamed Hishaam MA MD Emergency Medicine

IN IJr. Md1reen M()ha111111ad Shahid MS General Surgery

90 IJ, · Oasari Anurag MS Genera l Surgery

l)I !Jr. Chiral ia IJha ir_, i-t Shailcsh MS General Surgery

92 I JI{ . ANSA/{I AIJl::EL MS Genera l Surgery IN!\ MULi IA()UE S/ IAHNAZ

l)_J IJR. MAPA!{/ MfENAL SUNIL MS General Surgery

'J I 1)1{ . I\ 1l/\1'/\I< / Ml/KUL SUN/L M S Genera/ Surgery

6

Basic Workshop on RESEARCH METHODOLOGY 2019

Name: ……..………………………. (optional)

1

Pre / Post - TEST No. ITEM (Please tick appropriate)

1. In the FINER criteria for assessing the research question “I” stands for

A. Innovative

B. Interesting C. Inspiring D. Inclination

2. The authority to whom permission for conducting a clinical is to be asked for in India is A. Director, Indian Council of Medical Research B. Director General Health Services C. Drug Controller General of India D. Chairman, Medical Council of India

3. Among the following types of studies which one can be a “Hypothesis generating study?” A. Clinical trial

B. Case control study C. Cohort study D. Cross sectional study

4. Sampling frame is nothing but describing the A. Sampling method B. Procedure of calculating sample size

C. Population itself D. Inclusion & exclusion criteria

5. Making estimate about dependent variable from the independent variable for values beyond

the observed range of independent variable is: A. Interpolation

B. Extrapolation C. External validation D. Internal validation

6. The drawback/s of the open-ended question is/ are A. Likely hood of blanks B. Time consuming for coding C. Neither A nor B D. Both A & B

7. Harvard and Vancouver are the names for styles of A. Questionnaires B. Protocol writing C. Reference citation D. Sampling


Name: ……..………………………. (optional)

2

No. ITEM (Please tick appropriate)

8. Focus group discussion is a tool/ method used for A. Qualitative research B. Quantitative research C. Questionnaire designing D. Sampling

9. Ability of a test to detect disease in those who have it is its

A. Sensitivity B. Specificity C. Predictive power of positive test D. Predictive power of positive test

10. In Likert type of questions (in questionnaire) respondent is asked to indicate: A. How much he/she agrees with the statement B. Which of the statements he/she agrees C. Rank order of the statement D. Correct/ false answers.

11. One type of medical research in which informed consent may not be required and may not be

feasible is

A. Survey B. Case control study C. Cohort study D. None of the above

12. For testing the hypothesis about disease causation of a rare disease, the epidemiological study

of first choice is A: Cross sectional study

B: Case control study C: Cohort study D: Experimental study

13. The theoretical range of sensitivity of a screening test when compared with gold standard is A: Zero to one B: Minus 1 to plus 1 C: Zero to infinity

D: 1 to 100

14. For testing etiological hypothesis for a disease wherein you want to test more than one cause

(risk factor) the epidemiological study of choice will be A: Cross sectional study

B: Case control study C: Cohort study D: Experimental study


Name: ……..………………………. (optional)

3


15. When information in qualitative study is validated by collecting it from more than one source,

it is called A. Duplication

B. Triangulation C. Confirmation D. None of the above

16. In questionnaire, the type of questions that do not have a preset answer and respondent is

provided with a blank space for response are called: A. Close ended questions

B. Open ended questions C. Likert type of questions D. Babbie format style questions

17. In a class, students’ height does not show much variation. For this variable the population will

be considered as

A: Homogenous B: Heterogenous C: Dynamic D: Static

18. Data of 1000 patients is grouped into 3 groups as per severity of anemia: mild, moderate and

severe and is presented in tabular form. What is the scale of measurement here? A. Nominal

B. Ordinal C. Interval D. Ratio

19. In a hospital, due to turnover, patients stay for a brief period only. As such the age/sex

structure of patients shows variation over time. Thus, for these variables this will be A: A homogenous population B: A heterogenous population C: A dynamic population D: A static population

20. In statistics, the word "Parameter" refers to A: The constant that describe population characteristic B: The constant that describe sample's characteristic C: A property of normal curve D: A measure of variation used in advanced statistics


Name: ……..………………………. (optional)

4


21. Median is almost equal to ……….. percentile. A: 25 th

B: 50 th C: 80 th D: 90 th

22. In clinical trial "Reference Population" is the population A: To which the results of the study are applicable B: Which actually participates in the trial C: Which receives new drug being tested D: None of the above

23. As per ICMR guidelines, the responsibility of screening of the research proposals coming to

institutional ethics committee is assigned to: A. Chairman

B. Secretary C. Medical expert in the group D. Legal expert in the group

24. You are planning a clinical trial and you want to search if similar trials are planned anywhere

in world. The best and authentic source for this information is: A. World Health Organization: www.who.int/clinical trials B. Pubmed: www.ncbi.nlm.nih.gov/pubmed/clinicaltrials C: US National Institute of Health www.clinicaltrials.gov D: Google: www.google.com/ clinical trials

25. Assigning alphabetical/ numerical identifiers to responses from respondents in a questionnaire

is: A. Data editing B. Data reduction

C. Data coding D. Data embedding

26. Triangulation is a method of - A. Data collection B. Data presentation

C. Data validation D. Data analysis

27. In clinical trial "Study Population" refers to the population - A: To which the results of the study are applicable B: Which is eligible to participate in the trial C: Which receives new drug being tested D: None of the above


Name: ……..………………………. (optional)

5


28. According to ICMR guidelines a new drug is defined as -

A. a new chemical entity (NCE); B. a drug which has been approved for a certain indication, by a certain route, in a certain

dosage regimen, but which is now proposed to be used for another indication, by another

route, or in another dosage regimen

C. Both A & B D. Neither A nor B

29. A table in which first column represents labels (names) of groups and second column

represents the number corresponding to each group is A: Simple table B: Frequency distribution table C: Master table D: Two by two table

30. When testing the association of one cause (Risk factor) with two or more diseases (or

outcomes) is the objective of the study, the epidemiological study of first choice is A: Descriptive study B: Case control study

C: Cohort study D: Experimental study